Last updated: 7 March 2022 at 5:10pm EST

John E. Kennedy Net Worth




The estimated Net Worth of John Jed Kennedy is at least $2.18 Milione dollars as of 3 March 2022. Mr Kennedy owns over 7,714 units of Conmed stock worth over $784,105 and over the last 10 years he sold CNMD stock worth over $821,540. In addition, he makes $572,928 as Group Exec. VP of Advanced Endoscopic Technologies, QA/RA e Distribution & Customer Service at Conmed.

Mr Kennedy CNMD stock SEC Form 4 insiders trading

Mr has made over 22 trades of the Conmed stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 7,714 units of CNMD stock worth $527,560 on 3 March 2022.

The largest trade he's ever made was exercising 30,220 units of Conmed stock on 4 December 2019 worth over $1,333,911. On average, Mr trades about 5,493 units every 101 days since 2015. As of 3 March 2022 he still owns at least 10,687 units of Conmed stock.

You can see the complete history of Mr Kennedy stock trades at the bottom of the page.





Mr. John E. Kennedy biography

John E. Kennedy is the Group Exec. VP of Advanced Endoscopic Technologies, QA/RA, Distribution & Customer Service at Conmed.

What is the salary of Mr Kennedy?

As the Group Exec. VP of Advanced Endoscopic Technologies, QA/RA e Distribution & Customer Service of Conmed, the total compensation of Mr Kennedy at Conmed is $572,928. There are 4 executives at Conmed getting paid more, with Curt R. Hartman having the highest compensation of $1,787,620.



How old is Mr Kennedy?

Mr Kennedy is 63, he's been the Group Exec. VP of Advanced Endoscopic Technologies, QA/RA e Distribution & Customer Service of Conmed since . There are 1 older and 8 younger executives at Conmed. The oldest executive at Conmed Corp. is David R. Murray, 73, who is the Pres of ConMed Electrosurgery.

What's Mr Kennedy's mailing address?

John's mailing address filed with the SEC is C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO, FL, 33773.

Insiders trading at Conmed

Over the last 21 years, insiders at Conmed have traded over $105,028,573 worth of Conmed stock and bought 56,468 units worth $2,754,510 . The most active insiders traders include Jerome J. Lande, Joseph J Corasanti e Dirk Kuyper. On average, Conmed executives and independent directors trade stock every 8 days with the average trade being worth of $759,159. The most recent stock trade was executed by Charles Farkas on 5 September 2024, trading 1,000 units of CNMD stock currently worth $39,640.



What does Conmed do?

conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500



What does Conmed's logo look like?

Conmed Corp. logo

Complete history of Mr Kennedy stock trades at Conmed e Conmed

Data
#
Ditta
Persona
Trans.
Transazione
Azioni Prezzo per azione Prezzo totale Azioni dopo Fonte
3 Mar 2022 John Jed Kennedy
Group Executive Vice President
Opzione 7,714 $68.39 $527,560
3 Mar 2022
10,687
1 Mar 2022 John Jed Kennedy
Group Executive Vice President
Opzione 8,968 $26.40 $236,755
1 Mar 2022
9,965
2 Nov 2021 John Jed Kennedy
Group Executive Vice President
Opzione 9,462 $68.67 $649,756
2 Nov 2021
9,075
30 Aug 2021 John Jed Kennedy
Group Executive Vice President
Opzione 4,240 $46.70 $198,008
30 Aug 2021
7,575
27 Aug 2021 John Jed Kennedy
Group Executive Vice President
Opzione 5,438 $40.06 $217,846
27 Aug 2021
7,873
1 Mar 2021 John Jed Kennedy
Group Executive Vice President
Opzione 2,500 $122.55 $306,375
1 Mar 2021
7,742
16 Nov 2020 John Jed Kennedy
Group Executive Vice President
Vendita 1,589 $95.00 $150,955
16 Nov 2020
5,609
11 Nov 2020 John Jed Kennedy
Group Executive Vice President
Opzione 22,120 $51.10 $1,130,332
11 Nov 2020
9,098
28 Feb 2020 John Jed Kennedy
Group Executive Vice President
Opzione 1,575 $94.64 $149,058
28 Feb 2020
5,976
9 Dec 2019 John Jed Kennedy
Group Executive Vice President
Vendita 5,965 $112.42 $670,585
9 Dec 2019
4,497
5 Dec 2019 John Jed Kennedy
Group Executive Vice President
Opzione 19,520 $51.30 $1,001,376
5 Dec 2019
24,017
4 Dec 2019 John Jed Kennedy
Group Executive Vice President
Opzione 30,220 $44.14 $1,333,911
4 Dec 2019
19,816
25 Oct 2019 John Jed Kennedy
Group Executive Vice President
Opzione 600 $97.76 $58,656
25 Oct 2019
4,674
1 Mar 2019 John Jed Kennedy
Group Executive Vice President
Opzione 725 $78.76 $57,101
1 Mar 2019
4,187
26 Oct 2018 John Jed Kennedy
Group Executive Vice President
Opzione 600 $68.99 $41,394
26 Oct 2018
3,778
1 Mar 2018 John Jed Kennedy
Group Executive Vice President
Opzione 725 $59.96 $43,471
1 Mar 2018
3,291
26 Oct 2017 John Jed Kennedy
Group Executive Vice President
Opzione 560 $52.89 $29,618
26 Oct 2017
2,887
1 Mar 2017 John Jed Kennedy
Group Executive Vice President
Opzione 725 $41.93 $30,399
1 Mar 2017
2,450
26 Oct 2016 John Jed Kennedy
Group Executive Vice President
Opzione 560 $38.11 $21,342
26 Oct 2016
2,058
1 Mar 2016 John Jed Kennedy
Group Executive Vice President
Opzione 400 $39.87 $15,948
1 Mar 2016
1,649
26 Oct 2015 John Jed Kennedy
Group Executive Vice President
Opzione 560 $40.24 $22,534
26 Oct 2015
1,426
28 Feb 2020 John Jed Kennedy
VP GM CET
Opzione 1,575 $94.64 $149,058
28 Feb 2020
5,976


Conmed executives and stock owners

Conmed executives and other stock owners filed with the SEC include: